Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: A reappraisal of indications for organ failure supports

Journal of Clinical Oncology

Volumn 24, Issue 4, 2006, Pages 643-649

  Pène, Frédéric ^a   Aubron, Cécile ^a   Azoulay, Elie ^a   Blot, François ^a   Thiéry, Guillaume ^a   Raynard, Bruno ^a   Schlemmer, Benoît ^a   Nitenberg, Gêrard ^a   Buzyn, Agnés ^a   Arnaud, Philippe ^a   Socié, Gérard ^a   Mira, Jean Paul ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CORTICOSTEROID; VASOACTIVE AGENT;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ARTIFICIAL VENTILATION; BILIRUBIN BLOOD LEVEL; BLEEDING; CONTROLLED STUDY; ENDOTRACHEAL INTUBATION; ENGRAFTMENT; FEMALE; GRAFT VERSUS HOST REACTION; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; ISCHEMIA; KIDNEY FAILURE; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROGNOSIS; SHOCK; SURVIVAL RATE; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; VALVULAR HEART DISEASE; ACUTE DISEASE; ALLOTRANSPLANTATION; BLOOD; CLINICAL TRIAL; CRITICAL ILLNESS; FRANCE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; INTENSIVE CARE; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL;

ACUTE DISEASE; ADULT; BILIRUBIN; CRITICAL ILLNESS; FEMALE; FRANCE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PATIENT ADMISSION; PREDICTIVE VALUE OF TESTS; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 33644845172     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.03.9073     Document Type: Article

References (38)

1. Kress JP, Christenson J, Pohlman AS, et al: Outcomes of critically ill cancer patients in a university hospital setting. Am J Respir Crit Care Med 160:1957-1961, 1999
2. Staudinger T, Stoiser B, Mullner M, et al: Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med 28:1322-1328, 2000
3. Larche J, Azoulay E, Fieux F, et al: Improved survival of critically ill cancer patients with septic shock. Intensive Care Med 29:1688-1695, 2003
4. Azoulay E, Recher C, Alberti C, et al: Changing use of intensive care for hematological patients: The example of multiple myeloma. Intensive Care Med 25:1395-1401, 1999
5. Thiery G, Azoulay E, Darmon M, et al: Outcome of cancer patients considered for intensive care unit admission: A hospital-wide prospective study. J Clin Oncol 23:4406-4413, 2005
6. Hilbert G, Gruson D, Vargas F, et al: Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 344:481-487, 2001
7. Azoulay E, Alberti C, Bornstain C, et al: Improved survival in cancer patients requiring mechanical ventilatory support: Impact of noninvasive mechanical ventilatory support. Crit Care Med 29: 519-525, 2001
8. Ninin E, Milpied N, Moreau P, et al: Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. Clin Infect Dis 33:41-47, 2001
9. Champlin RE, Schmitz N, Horowitz MM, et al: Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation: IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). Blood 95:3702-3709, 2000
10. Socie G, Stone JV, Wingard JR, et al: Long-term survival and late deaths after allogeneic bone marrow transplantation: Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 341:14-21, 1999
11. Maury S, Mary JY, Rabian C, et al: Prolonged immune deficiency following allogeneic stem cell transplantation: Risk factors and complications in adult patients. Br J Haematol 115:630-641, 2001
12. Faber-Langendoen K, Caplan AL, McGlave PB: Survival of adult bone marrow transplant patients receiving mechanical ventilation: A case for restricted use. Bone Marrow Transplant 12:501-507, 1993
13. Paz HL, Crilley P, Weinar M, et al: Outcome of patients requiring medical ICU admission following bone marrow transplantation. Chest 104:527-531, 1993
14. Rubenfeld GD, Crawford SW: Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: A case for evidence-based guidelines. Ann Intern Med 125:625-633, 1996
15. Paz HL, Garland A, Weinar M, et al: Effect of clinical outcomes data on intensive care unit utilization by bone marrow transplant patients. Crit Care Med 26:66-70, 1998
16. Jackson SR, Tweeddale MG, Barnett MJ, et al: Admission of bone marrow transplant recipients to the intensive care unit: Outcome, survival and prognostic factors. Bone Marrow Transplant 21:697-704, 1998
17. Shorr AF, Moores LK, Edenfield WJ, et al: Mechanical ventilation in hematopoietic stem cell transplantation: Can we effectively predict outcomes? Chest 116:1012-1018, 1999
18. Khassawneh BY, White P Jr, Anaissie EJ, et al: Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation. Chest 121:185-188, 2002
19. Soubani AO, Kseibi E, Bander JJ, et al: Outcome and prognostic factors of hematopoietic stem cell transplantation recipients admitted to a medical ICU. Chest 126:1604-1611, 2004
20. Bach PB, Schrag D, Nierman DM, et al: Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation. Blood 98:3234-3240, 2001
21. Afessa B, Tefferi A, Dunn WF, et al: Intensive care unit support and Acute Physiology and Chronic Health Evaluation III performance in hematopoietic stem cell transplant recipients. Crit Care Med 31: 1715-1721, 2003
22. Groeger JS, Lemeshow S, Price K, et al: Multicenter outcome study of cancer patients admitted to the intensive care unit: A probability of mortality model. J Clin Oncol 16:761-770, 1998
23. Groeger JS, White P Jr, Nierman DM, et al: Outcome for cancer patients requiring mechanical ventilation. J Clin Oncol 17:991-997, 1999
24. Price KJ, Thall PF, Kish SK, et al: Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit. Am J Respir Crit Care Med 158:876-884, 1998
25. Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS III based on a European/North American multicenter study. JAMA 270:2957-2963, 1993
26. Le Gall JR, Klar J, Lemeshow S, et al: The Logistic Organ Dysfunction system: A new way to assess organ dysfunction in the intensive care unit - ICU Scoring Group. JAMA 276:802-810, 1996
27. Richardson PG, Murakami C, Jin Z, et al: Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: Response without significant toxicity in a high-risk population and factors predictive of outcome. Blood 100:4337-4343, 2002
28. Blot F, Guiguet M, Nitenberg G, et al: Prognostic factors for neutropenic patients in an intensive care unit: Respective roles of underlying malignancies and acute organ failures. Eur J Cancer 33:1031-1037, 1997
29. Benoit DD, Vandewoude KH, Decruyenaere JM, et al: Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit Care Med 31:104-112, 2003
30. Fukuda T, Boeckh M, Carter RA, et al: Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 102:827-833, 2003
31. Esteban A, Anzueto A, Frutos F, et al: Characteristics and outcomes in adult patients receiving mechanical ventilation: A 28-day international study. JAMA 287:345-355, 2002
32. ARDS Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome: The Acute Respiratory Distress Syndrome Network. N Engl J Med 342:1301-1308, 2000
33. Herridge MS, Cheung AM, Tansey CM, et al: One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 348:683-693, 2003
34. Ruutu T, Eriksson B, Remes K, et al: Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation. Blood 100:1977-1983, 2002
35. Azoulay E, Thiery G, Chevret S, et al: The prognosis of acute respiratory failure in critically ill cancer patients. Medicine (Baltimore) 83:360-370, 2004
36. Huaringa AJ, Leyva FJ, Giralt SA, et al: Outcome of bone marrow transplantation patients requiring mechanical ventilation. Crit Care Med 28: 1014-1017, 2000
37. Andrykowski MA, Bishop MM, Hahn EA, et al: Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol 23:599-608, 2005
38. Nelson JE, Meier DE, Oei EJ, et al: Self-reported symptom experience of critically ill cancer patients receiving intensive care. Crit Care Med 29:277-282, 2001